.jpg)
.jpg)
.jpg)
Recommended
Breaking News
FDA Approves Expanded Label for Iluvien to Include Chronic Noninfectious Uveitis
Mar 17, 2025
The FDA has approved an expanded label for Iluvien, allowing its use for the treatment of chronic noninfectious uveitis affecting the posterior segment of the eye, ANI Pharmaceuticals announced in a press release.
Atsena Therapeutics Receives FDA Fast Track Designation for ATSN-201 Gene Therapy in X-Linked Retinoschisis
Mar 13, 2025
Atsena Therapeutics has been granted Fast Track designation by the FDA for ATSN-201, its investigational gene therapy designed to treat X-linked retinoschisis (XLRS), a rare inherited retinal disease with no approved treatments.
Sydnexis Announces FDA Acceptance of NDA for SYD-101 in Pediatric Myopia Treatment
Mar 12, 2025
Sydnexis has reached a significant regulatory milestone with the FDA’s acceptance of its New Drug Application (NDA) for SYD-101, a potential first-in-class pharmaceutical treatment for the progression of pediatric myopia in the United States.
.jpg)
Industry News
HanAll Biopharma Secures Orphan Drug Designation in Japan for Batoclimab to Treat Thyroid Eye Disease
Mar 19, 2025
HanAll Biopharma has received Orphan Drug Designation (ODD) from the Ministry of Health, Labor and Welfare (MHLW) in Japan for Batoclimab, an anti-FcRn monoclonal antibody developed for autoimmune diseases, including active thyroid eye disease (TED).
Iantrek’s Bio-Interventional Technology Shows Positive Glaucoma Surgery Results
Mar 19, 2025
Iantrek Corporation has released promising results from its two-year clinical study on bio-reinforced cyclodialysis technology, highlighting its effectiveness in enhancing uveoscleral outflow for glaucoma patients.
China Approves First IGF-1R Monoclonal Antibody for Thyroid Eye Disease, Innovent Biologics Announces
Mar 18, 2025
China has approved SYCUME, the country’s first monoclonal antibody treatment for thyroid eye disease (TED), developed by Innovent Biologics.
Ophthalmic Research News
New Study Highlights Racial and Economic Barriers in Glaucoma Care Access
Mar 19, 2025
A new study from Northwestern University reveals that racial, economic, and geographic factors significantly impact access to glaucoma care in the United States.
Researchers Develop Pig Retinal Cells to Advance Eye Treatments
Mar 17, 2025
Scientists at the University of Wisconsin-Madison have successfully developed pig retinal organoids, opening new pathways for testing and advancing stem cell therapies for vision loss.
f-ORG Technique Revolutionizes Early Detection of Retinal Diseases
Mar 17, 2025
Eye diseases often develop unnoticed for years, making early detection crucial. Scientists at the International Centre for Eye Research (ICTER) have introduced a groundbreaking diagnostic method called flicker optoretinography (f-ORG).
Ophthalmic Blog
AI in Ophthalmology: Top Artificial Intelligence Tools Transforming Eye Health
Mar 07, 2025
The AI in ophthalmology sector is evolving rapidly, introducing Artificial Intelligence tools in ophthalmology that enhance diagnostic accuracy, efficiency, and accessibility.
2024 Recap: Top 8 Groundbreaking Innovations in Eye Disease Therapies and Technologies
Dec 23, 2024
The year 2024 has been a remarkable period for advancements in ophthalmology, with groundbreaking innovations reshaping the landscape of eye disease treatment and diagnosis.
2024 Recap: Top 8 FDA Approvals in Ophthalmology
Dec 16, 2024
The year 2024 has been a pivotal one for ophthalmology, with several novel FDA approvals introducing innovative treatments and technologies to the field
Ophthalmology Breaking News Subscribe